Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars.
LSTR
Triple Antibiotic Paste Versus Simvastatin for LSTR Treatment of Primary Molars With Pulp Necrosis: A Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized, double-blinded, parallel-controlled clinical trial aims to compare the effectiveness of Triple Antibiotic Paste (TAP) and Simvastatin in Lesion Sterilization and Tissue Repair (LSTR) of primary molars with pulp necrosis. A total of 60 children (aged 5-8 years) with non-vital primary molars will be recruited from the Department of Operative Dentistry and Endodontics, Dow International Dental College, Karachi. Participants will be randomly assigned to one of two groups: Group 1 (Control): LSTR using Triple Antibiotic Paste (Ciprofloxacin + Metronidazole + Cefixime). Group 2 (Intervention): LSTR using Simvastatin paste. Both materials will be placed after non-instrumentation cleaning and sealed with glass ionomer cement, followed by stainless steel crown placement. Patients will be evaluated clinically and radiographically at 1, 2, and 3 months post-treatment. Primary outcomes include clinical success (absence of pain, swelling, or sinus tract) and radiographic success (reduction or absence of periapical radiolucency). Data will be analyzed using SPSS v26, with chi-square and t-tests applied as appropriate; p \< 0.05 will be considered significant. This study seeks to determine whether Simvastatin, owing to its antibacterial, anti-inflammatory, and regenerative properties, can serve as a viable alternative to antibiotic-based LSTR in managing necrotic primary teeth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 26, 2024
CompletedFirst Submitted
Initial submission to the registry
November 24, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
ExpectedMarch 10, 2026
March 1, 2026
1.8 years
November 24, 2025
March 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical Success
Change in pain through visual analog scale and size of swelling in millimeters will be assessed to measure clinical success.
1 month, 2 month and 3 month.
Radiographic success
Change in radiolucency through the periapical index will be measured to assess radiographic success.
1 month, 2 month and 3 month
Study Arms (2)
Simvastatin
EXPERIMENTALLesion Sterilization and Tissue Repair using Simvastatin.
Triple Antibiotic Paste
ACTIVE COMPARATORLesion Sterilization and Tissue Repair using triple antibiotic paste
Interventions
Lesion sterilization and Tissue Repair includes removal of any debris from the pulp chamber of the primary tooth and filling with simvastatin followed by sealed with the restoration.
Lesion sterilization and Tissue Repair includes removal of any debris from the pulp chamber of the primary tooth and filling with triple antibiotic paste followed by sealed with the restoration.
Eligibility Criteria
You may qualify if:
- Young, healthy patient, ranging in age from 5-8 years.
- Has parents/ guardians who give consent to allow their minor to participate in the study and willing to monitor their progress.
- Having maxillary and mandibular primary molars with:
- Spontaneous pain or tenderness to percussion.
- Deep cavity extending to the pulp chamber.
- Chronic Abscess or draining sinus.
- Restorable.
- To be kept for less than a year.
- Irregular mobility that is not related to exfoliation.
You may not qualify if:
- Uncooperative patients.
- Children with a history of allergic reaction with antibiotics.
- Teeth with physiological root resorption but root length is more than two thirds, root canal obliteration, severe internal resorption, internal calcifications, or piercing into the bifurcation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dow International Dental College, Chanesar goth.
Karachi, Sindh, 75950, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Prof.Dr. Farah Naz Biyabani, FCPS
Dow University of Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postgraduate Trainee- FCPS
Study Record Dates
First Submitted
November 24, 2025
First Posted
December 4, 2025
Study Start
June 26, 2024
Primary Completion
April 30, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
March 10, 2026
Record last verified: 2026-03